查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1319052

器官移植免疫抑制藥物市場：依功效等級、移植類型、通路分類 - 全球預測 2023-2030

Organ Transplant Immunosuppressant Drugs Market by Drug Class, Transplant Type, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球器官移植免疫抑制劑市場規模將達424,374萬美元，複合年成長率為7.02%，大幅成長，2030年將達685,546萬美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球器官移植免疫抑制藥物市場至關重要。透過檢視業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使用戶能夠根據自己的具體需求做出資訊的決策。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球器官移植免疫抑制劑市場規模及預測如何？

2.在預測期內，COVID-19對全球器官移植免疫抑制劑市場的阻礙因素與影響有哪些？

3. 在預測期內，全球器官移植免疫抑制劑市場需要投資哪些產品/細分市場/應用/領域？

4.全球器官移植免疫抑制藥物市場的競爭策略為何？

5.全球器官移植免疫抑制劑市場的技術趨勢與法律規範如何？

6.全球器官移植免疫抑制藥物市場主要廠商的市佔率如何？

7. 哪些型態和策略措施被認為適合進入全球器官移植免疫抑制劑市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 器官移植需求增加
      • 新產品法規核准增加
      • 政府和非政府組織配合措施促進器官捐贈
    • 抑制因素
      • 缺乏專注於研究免疫抑制劑的醫療專業人員
    • 機會
      • 器官移植藥物開發的廣泛技術發展
      • 器官移植免疫抑制劑可享優惠報銷
    • 任務
      • 缺乏可行的器官
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 依藥物類別分類的器官移植免疫抑制劑市場

  • 抗體
  • 抗增殖劑
  • 鈣調磷酸酶抑制劑
  • mTOR抑制劑
  • 類固醇

第7章 依移植類型分類的器官移植免疫抑制劑藥物市場

  • 心
  • 腎
  • 肝
  • 肺
  • 胰臟

第8章 器官移植免疫抑制劑市場：依分銷管道分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第9章 美洲器官移植免疫抑制劑藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太器官移植免疫抑制劑藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲器官移植免疫抑制劑藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-AD36CD897E2B

The Global Organ Transplant Immunosuppressant Drugs Market is forecasted to grow significantly, with a projected USD 4,243.74 million in 2023 at a CAGR of 7.02% and expected to reach a staggering USD 6,855.46 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Organ Transplant Immunosuppressant Drugs Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Organ Transplant Immunosuppressant Drugs Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug Class, market is studied across Antibodies, Antiproliferative Agents, Calcineurin Inhibitors, mTOR Inhibitor, and Steroids. The Antibodies is projected to witness significant market share during forecast period.

Based on Transplant Type, market is studied across Heart, Kidney, Liver, Lung, and Pancreas. The Pancreas is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Retail Pharmacies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Organ Transplant Immunosuppressant Drugs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Organ Transplant Immunosuppressant Drugs Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Organ Transplant Immunosuppressant Drugs Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Organ Transplant Immunosuppressant Drugs Market?

4. What is the competitive strategic window for opportunities in the Global Organ Transplant Immunosuppressant Drugs Market?

5. What are the technology trends and regulatory frameworks in the Global Organ Transplant Immunosuppressant Drugs Market?

6. What is the market share of the leading vendors in the Global Organ Transplant Immunosuppressant Drugs Market?

7. What modes and strategic moves are considered suitable for entering the Global Organ Transplant Immunosuppressant Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Organ Transplant Immunosuppressant Drugs Market, by Drug Class, 2022 vs 2030
  • 4.3. Organ Transplant Immunosuppressant Drugs Market, by Transplant Type, 2022 vs 2030
  • 4.4. Organ Transplant Immunosuppressant Drugs Market, by Distribution Channel, 2022 vs 2030
  • 4.5. Organ Transplant Immunosuppressant Drugs Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for organ transplantation
      • 5.1.1.2. Growing approval for new products by the regulatory bodies
      • 5.1.1.3. Government & NGO initiatives promoting organ donation
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of medical professionals focused on immunosuppressants research
    • 5.1.3. Opportunities
      • 5.1.3.1. Extensive technological developments in organ transplants drug development
      • 5.1.3.2. Favorable reimbursement available for organ transplant immunosuppressant drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of availability of viable organs
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Organ Transplant Immunosuppressant Drugs Market, by Drug Class

  • 6.1. Introduction
  • 6.2. Antibodies
  • 6.3. Antiproliferative Agents
  • 6.4. Calcineurin Inhibitors
  • 6.5. mTOR Inhibitor
  • 6.6. Steroids

7. Organ Transplant Immunosuppressant Drugs Market, by Transplant Type

  • 7.1. Introduction
  • 7.2. Heart
  • 7.3. Kidney
  • 7.4. Liver
  • 7.5. Lung
  • 7.6. Pancreas

8. Organ Transplant Immunosuppressant Drugs Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Organ Transplant Immunosuppressant Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Organ Transplant Immunosuppressant Drugs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2022 VS 2030 (%)
  • FIGURE 5. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2022 VS 2030 (%)
  • FIGURE 6. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • FIGURE 7. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET DYNAMICS
  • FIGURE 9. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 5. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY ANTIPROLIFERATIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY MTOR INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY STEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY KIDNEY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY PANCREAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 17. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 148. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 149. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET LICENSE & PRICING